Key Takeaways
- NIH researchers created a 4D brain map in an animal model of multiple sclerosis (MS), revealing how MS-like lesions form.
- The study identified a new MRI signature to detect brain regions at risk for damage before visible lesions appear.
- Findings may inform future MS treatments and provide insights into other brain injuries beyond MS.
Researchers at the National Institutes of Health (NIH) have made significant strides in understanding multiple sclerosis (MS) by developing a four-dimensional brain map using an animal model. This groundbreaking research, published in the journal Science, sheds light on how lesions akin to those in human MS develop, offering potential targets for treatment and brain tissue repair.
Led by postdoctoral fellow Jing-Ping Lin, Ph.D., and senior investigator Daniel S. Reich, M.D., Ph.D., at the NIH’s National Institute of Neurological Disorders and Stroke (NINDS), the team employed a combination of repeated MRI imaging and intricate brain-tissue analyses, including examining gene expression. Their efforts revealed a novel MRI signature capable of detecting susceptible brain regions weeks before any lesions manifest. They also categorized specific “microenvironments” within the affected brain tissue, focusing on neural function patterns, inflammation, immune responses, gene expression, and damage and repair levels.
“Identifying the early events that occur after inflammation and differentiating reparative from damaging processes can potentially allow us to better recognize MS disease activity earlier and innovate treatments to decelerate or halt its progression,” Dr. Reich explained.
MS is characterized by the immune system’s attack on myelin, the protective sheath surrounding nerve fibers. This leads to inflammation, myelin loss, and the formation of lesions or plaques within the brain. Historically, research on MS progression has relied heavily on postmortem human brain tissue samples, typically analyzed decades after the disease’s initial onset, which neglects critical early changes that occur before symptoms arise.
Unlike traditional mouse models, the researchers chose to use marmosets, a nonhuman primate model that more accurately reflects human brain conditions. Marmoset brains, having a higher white matter-to-gray matter ratio than mouse brains, allowed for the creation of multiple lesions that closely resemble those seen in human MS. This model allows real-time tracking of lesions and a better understanding of the initial stages of inflammation and immune responses leading to MS-like demyelination.
One significant discovery was the role of a specific type of astrocyte, a supportive brain cell, that activates a gene called SERPINE1 or plasminogen activator inhibitor-1 (PAI1). These astrocytes were found clustering near vulnerable brain borders prior to any visible damage, indicating potential future lesion sites. They also appeared to influence the behavior of surrounding cells, including immune cells, potentially amplifying inflammation and affecting myelin repair processes.
The dual role of SERPINE1-expressing astrocytes in promoting either tissue repair or further damage raises intriguing questions for further research. “If one imagines a fort under siege, initially the walls might hold off the attack; however, if those walls are breached, the defenses inside can turn against the fort itself,” Dr. Reich noted.
These findings not only hold promise for MS treatments but may also extend to understanding various brain injuries, such as traumatic brain injury, stroke, and inflammation. The common reactions to injury elucidated in this study could act as a reference for diverse neurological conditions.
The research team is also working on a model for another autoimmune disorder affecting brain borders and aims to expand their data set to include aged animals, enhancing the understanding of progressive MS, which currently lacks effective therapeutic options.
The content above is a summary. For more details, see the source article.